{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Water+Spray+Only", "query": { "intervention": "Water Spray Only" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Water+Spray+Only&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T15:33:29.795Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06366503", "title": "Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Photoaging", "Wrinkle", "Skin Laxity" ], "interventions": [ { "name": "Fractional Ablative CO2 Laser", "type": "PROCEDURE" }, { "name": "Facial Cleanser", "type": "OTHER" }, { "name": "Facial Moisturizer", "type": "OTHER" }, { "name": "Sunscreen", "type": "OTHER" }, { "name": "Basic Ointment", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Revision Skincare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "35 Years to 65 Years · Female only" }, "enrollment_count": 23, "start_date": "2023-10-03", "completion_date": "2023-12-29", "has_results": false, "last_update_posted_date": "2025-08-03", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Blue Ash, Ohio", "locations": [ { "city": "Blue Ash", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06366503" }, { "nct_id": "NCT00665977", "title": "Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea", "Nasal Congestion", "Sinus Congestion" ], "interventions": [ { "name": "Thermosmart & placebo", "type": "DRUG" }, { "name": "Placebo Device & Nasacort", "type": "DRUG" }, { "name": "Placebo Arm", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Clayton Sleep Insititute", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2007-09", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-07-07", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00665977" }, { "nct_id": "NCT01648257", "title": "Relative Bioavailability Study of GSK1265744 Formulations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infections, Human Immunodeficiency Virus and Hepatitis" ], "interventions": [ { "name": "GSK1265744 Na Salt Tablets", "type": "DRUG" }, { "name": "GSK1265744 Free Acid Nanomilled Capsules", "type": "DRUG" }, { "name": "GSK1265744 Free Acid Micronized Capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 18, "start_date": "2012-08", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2016-08-12", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01648257" }, { "nct_id": "NCT02156557", "title": "Study of KCC Peptide Application in the Colon", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colon Polyps", "Colorectal Cancer", "Inflammatory Bowel Disease (IBD)" ], "interventions": [ { "name": "Colon KCC Heptapeptide", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Danielle Kim Turgeon", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 45, "start_date": "2014-06", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2017-04-04", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02156557" }, { "nct_id": "NCT00223691", "title": "Treatment of Orthostatic Hypotension in Autonomic Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Failure", "Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Yohimbine", "type": "DRUG" }, { "name": "Midodrine HCl", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "water intake", "type": "OTHER" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" }, { "name": "Ranitidine HCL", "type": "DRUG" }, { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Ergotamine/ Caffeine", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pseudoephedrine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxymetazoline 0.05% nasal solution", "type": "DRUG" }, { "name": "Bovril", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Rivastigmine tartrate", "type": "DRUG" }, { "name": "Carbidopa/levodopa", "type": "DRUG" }, { "name": "Inflatable abdominal binder", "type": "DEVICE" }, { "name": "inflatable abdominal binder (sham)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 389, "start_date": "2002-03", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223691" }, { "nct_id": "NCT04072146", "title": "Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "Vaenicline oral tablet 1 mg, then OC-01 (varenicline solution) nasal spray 0.12 mg", "type": "DRUG" }, { "name": "OC-01 (varenicline solution) nasal spray 0.12 mg then Varenicline oral tablet 1 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oyster Point Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 22, "start_date": "2019-08-26", "completion_date": "2019-11-15", "has_results": true, "last_update_posted_date": "2022-05-23", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04072146" }, { "nct_id": "NCT01194089", "title": "Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Nasal Nicotine Spray", "type": "DRUG" }, { "name": "Nasal Normal Saline Spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Toby Weingarten", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 95, "start_date": "2010-08", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2015-07-09", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01194089" }, { "nct_id": "NCT04738838", "title": "Oxytocin on Cold Water Task Performance and Recovery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cold Exposure" ], "interventions": [ { "name": "Oxytocin nasal spray", "type": "DRUG" }, { "name": "Placebo nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Florida Institute for Human and Machine Cognition", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "MALE", "summary": "18 Years to 39 Years · Male only" }, "enrollment_count": 17, "start_date": "2022-05-20", "completion_date": "2022-07-29", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 2, "location_summary": "Gainesville, Florida • Pensacola, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04738838" }, { "nct_id": "NCT02251288", "title": "A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Avian Influenza", "Immunisation" ], "interventions": [ { "name": "Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca", "type": "BIOLOGICAL" }, { "name": "Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013", "type": "BIOLOGICAL" }, { "name": "MF59 adjuvant", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "47 Years", "sex": "ALL", "summary": "18 Years to 47 Years" }, "enrollment_count": 62, "start_date": "2015-05-18", "completion_date": "2018-08-17", "has_results": false, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02251288" }, { "nct_id": "NCT01507610", "title": "Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Sumatriptan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Optinose US Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 20, "start_date": "2012-01", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2012-02-29", "last_synced_at": "2026-09-04T15:33:29.795Z", "location_count": 1, "location_summary": "Neptune City, New Jersey", "locations": [ { "city": "Neptune City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01507610" } ] }